Reuters logo
BRIEF-Emblem Corp. And Dosecann Inc. Sign Licensing Deal To Develop Dosage-Controlled Formulations
December 21, 2017 / 1:11 PM / a month ago

BRIEF-Emblem Corp. And Dosecann Inc. Sign Licensing Deal To Develop Dosage-Controlled Formulations

Dec 21 (Reuters) - Emblem Corp:

* EMBLEM CORP. AND DOSECANN INC. SIGN LICENSING DEAL TO DEVELOP DOSAGE-CONTROLLED FORMULATIONS Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below